BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 9367418)

  • 21. [Isotyping of human C4 complement using differences in the functional activity of C4A and C4B isotypes].
    Kozlov LV; Lakhtin VM; Skorokhodova TG; Batalova TN; Shoĭbonov BB; D'iakov VL; Guzova VA; Matveevskaia NS
    Bioorg Khim; 2000 Jul; 26(7):539-47. PubMed ID: 11008645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A soluble recombinant multimeric anti-Rh(D) single-chain Fv/CR1 molecule restores the immune complex binding ability of CR1-deficient erythrocytes.
    Oudin S; Libyh MT; Goossens D; Dervillez X; Philbert F; Réveil B; Bougy F; Tabary T; Rouger P; Klatzmann D; Cohen JH
    J Immunol; 2000 Feb; 164(3):1505-13. PubMed ID: 10640768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement receptor type 1 (CR1, CD35) is a receptor for C1q.
    Klickstein LB; Barbashov SF; Liu T; Jack RM; Nicholson-Weller A
    Immunity; 1997 Sep; 7(3):345-55. PubMed ID: 9324355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
    Pascual M; Schifferli JA
    Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis.
    Klickstein LB; Bartow TJ; Miletic V; Rabson LD; Smith JA; Fearon DT
    J Exp Med; 1988 Nov; 168(5):1699-717. PubMed ID: 2972794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control of the function of substrate-bound C4b-C3b by the complement receptor Cr1.
    Medof ME; Nussenzweig V
    J Exp Med; 1984 Jun; 159(6):1669-85. PubMed ID: 6233387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The structure and role of CR1 complement receptor in physiology].
    Rochowiak A; Niemir ZI
    Pol Merkur Lekarski; 2010 Jan; 28(163):79-83. PubMed ID: 20369732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b.
    Birmingham DJ; Chen W; Liang G; Schmitt HC; Gavit K; Nagaraja HN
    Immunology; 2003 Apr; 108(4):531-8. PubMed ID: 12667215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding of C3b and C4b by the CR1-like site in murine CR1.
    Kalli KR; Fearon DT
    J Immunol; 1994 Mar; 152(6):2899-903. PubMed ID: 8144890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of complement receptor type 1 (CR1, CD35) in determining the cellular distribution of opsonized immune complexes between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes.
    Nielsen CH; Matthiesen SH; Lyng I; Leslie RG
    Immunology; 1997 Jan; 90(1):129-37. PubMed ID: 9038723
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Catabolism of the human erythrocyte C3b/C4b receptor (CR1, CD35): vesiculation and/or proteolysis?
    Dervillez X; Oudin S; Libyh MT; Tabary T; Reveil B; Philbert F; Bougy F; Pluot M; Cohen JH
    Immunopharmacology; 1997 Dec; 38(1-2):129-40. PubMed ID: 9476124
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The role of CR1 complement receptor in pathology].
    Rochowiak A; Niemir ZI
    Pol Merkur Lekarski; 2010 Jan; 28(163):84-8. PubMed ID: 20369733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defining targets for complement components C4b and C3b on the pathogenic neisseriae.
    Lewis LA; Ram S; Prasad A; Gulati S; Getzlaff S; Blom AM; Vogel U; Rice PA
    Infect Immun; 2008 Jan; 76(1):339-50. PubMed ID: 17984207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduced erythrocyte CR1 (CD 35) receptor function and complement opsonization in factor I-deficient patients is restored by plasma infusion.
    Jepsen HH; Teisner B; Rasmussen JM; Svehag SE
    Scand J Immunol; 1989 Feb; 29(2):247-55. PubMed ID: 2522236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Covalently-bound human C4b dimers consisting of C4B isotype show higher hemolytic activity than those of C4A in the C3-bypass complement pathway.
    Masaki T; Matsumoto M; Hara T; Nakanishi I; Kitamura H; Seya T
    Mol Immunol; 1995 Jan; 32(1):21-6. PubMed ID: 7870055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
    Ng YC; Schifferli JA; Walport MJ
    Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factor I-dependent inactivation of human complement C4b of the classical pathway by C3b/C4b receptor (CR1, CD35) and membrane cofactor protein (MCP, CD46).
    Masaki T; Matsumoto M; Nakanishi I; Yasuda R; Seya T
    J Biochem; 1992 May; 111(5):573-8. PubMed ID: 1386357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of immune complexes to erythrocyte CR1 (CD35): difference in requirement of classical pathway components and indication of alternative pathway-mediated binding in C2-deficiency.
    Klint C; Gullstrand B; Sturfelt G; Truedsson L
    Scand J Immunol; 2000 Jul; 52(1):103-8. PubMed ID: 10886790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Using mutagenesis and structural biology to map the binding site for the Plasmodium falciparum merozoite protein PfRh4 on the human immune adherence receptor.
    Park HJ; Guariento M; Maciejewski M; Hauhart R; Tham WH; Cowman AF; Schmidt CQ; Mertens HD; Liszewski MK; Hourcade DE; Barlow PN; Atkinson JP
    J Biol Chem; 2014 Jan; 289(1):450-63. PubMed ID: 24214979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure-function relationships of complement receptor type 1.
    Krych-Goldberg M; Atkinson JP
    Immunol Rev; 2001 Apr; 180():112-22. PubMed ID: 11414353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.